Product Information
SOLIQUA 100 UNIT-33 MCG/ML PEN is a brand product labeled by Sanofi-Aventis U.S. LLC, priced at $57.0959 per ML under NDC 00024576105. Its NADAC has been published 476 times since May 17, 2017.
Strength
100; 33 U/mL; ug/mL
Manufacturer
Sanofi-Aventis U.S. LLCNDC
00024576105
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
INSULIN GLARGINE; LIXISENATIDEApproval Type
Biologic (BLA)
FDA Application
BLA208673On Market Since
11/21/2016
Pharmacological Classes
Price Statistics
The NADAC for SOLIQUA 100 UNIT-33 MCG/ML PEN has been published 476 times since May 17, 2017, and over the history we have for it it has risen 41.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $57.0959 per ML |
|---|---|
| All-time high | $57.1294 (Aug 14, 2024) |
| All-time low | $40.4055 (May 17, 2017) |
| 52-week high | $57.0959 |
| 52-week low | $57.0547 |
| Median price | $49.4609 |
| Average price | $50.2088 |
| Largest weekly change | +5.8% (Jan 17, 2018) |
| Weeks tracked | 476 |
| Tracking since | May 17, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the insulin glargine and lixisenatide market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of SOLIQUA 100 UNIT-33 MCG/ML PEN?
The current National Average Drug Acquisition Cost (NADAC) for SOLIQUA 100 UNIT-33 MCG/ML PEN, manufactured by Sanofi-Aventis U.S. LLC, is $57.0959 per ML (NDC 00024576105), effective Jun 24, 2026.
How has the price of SOLIQUA 100 UNIT-33 MCG/ML PEN changed over time?
Over the history we have for it, the NADAC for SOLIQUA 100 UNIT-33 MCG/ML PEN has risen 41.3%. It has been tracked across 476 weekly CMS publications since May 17, 2017.
What are the highest and lowest recorded NADAC prices for SOLIQUA 100 UNIT-33 MCG/ML PEN?
Since May 17, 2017, the NADAC for SOLIQUA 100 UNIT-33 MCG/ML PEN has ranged from a low of $40.4055 (May 17, 2017) to a high of $57.1294 (Aug 14, 2024), with a median of $49.4609 per ML.
Are there cheaper alternatives to SOLIQUA 100 UNIT-33 MCG/ML PEN?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of SOLIQUA 100 UNIT-33 MCG/ML PEN, so no direct lower-cost alternative is listed.
Who manufactures SOLIQUA 100 UNIT-33 MCG/ML PEN?
SOLIQUA 100 UNIT-33 MCG/ML PEN (NDC 00024576105) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification